Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification

BACKGROUND: To date, no standard follow-up guidelines exist regarding patients receiving ablation for initial recurrent hepatocellular carcinoma (HCC). We aimed to explore whether intensive follow-up could benefit these patients. METHODS: We reviewed the clinical data of patients who received comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xuqi, Li, Lingling, Lyu, Ning, Mu, Luwen, Lai, Jinfa, Zhao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329485/
https://www.ncbi.nlm.nih.gov/pubmed/32611383
http://dx.doi.org/10.1186/s40644-020-00319-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329485/
https://www.ncbi.nlm.nih.gov/pubmed/32611383
http://dx.doi.org/10.1186/s40644-020-00319-w

Ejemplares similares